Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions

Transient receptor potential ion channel, vanilloid subfamily, type 1 (TRPV1) cation channel, and cannabinoid receptor 1 (CB1) are essential in the modulation of nociceptive signaling in the spinal cord dorsal horn that underlies different pathological pain states. TRPV1 and CB1 receptors share the...

Full description

Bibliographic Details
Main Authors: Diana Spicarova, Vladimir Nerandzic, David Muzik, Monica Pontearso, Anirban Bhattacharyya, Istvan Nagy, Jiri Palecek
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnmol.2023.1188503/full
_version_ 1797797756032516096
author Diana Spicarova
Vladimir Nerandzic
David Muzik
Monica Pontearso
Anirban Bhattacharyya
Istvan Nagy
Istvan Nagy
Jiri Palecek
author_facet Diana Spicarova
Vladimir Nerandzic
David Muzik
Monica Pontearso
Anirban Bhattacharyya
Istvan Nagy
Istvan Nagy
Jiri Palecek
author_sort Diana Spicarova
collection DOAJ
description Transient receptor potential ion channel, vanilloid subfamily, type 1 (TRPV1) cation channel, and cannabinoid receptor 1 (CB1) are essential in the modulation of nociceptive signaling in the spinal cord dorsal horn that underlies different pathological pain states. TRPV1 and CB1 receptors share the endogenous agonist anandamide (AEA), produced from N-arachidonoylphosphatidylethanolamine (20:4-NAPE). We investigated the effect of the anandamide precursor 20:4-NAPE on synaptic activity in naive and inflammatory conditions. Patch-clamp recordings of miniature excitatory postsynaptic currents (mEPSCs) from superficial dorsal horn neurons in rat acute spinal cord slices were used. Peripheral inflammation was induced by subcutaneous injection of carrageenan. Under naive conditions, mEPSCs frequency (0.96 ± 0.11 Hz) was significantly decreased after 20 μM 20:4-NAPE application (55.3 ± 7.4%). This 20:4-NAPE-induced inhibition was blocked by anandamide-synthesizing enzyme N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor LEI-401. In addition, the inhibition was prevented by the CB1 receptor antagonist PF 514273 (0.2 μM) but not by the TRPV1 receptor antagonist SB 366791 (10 μM). Under inflammatory conditions, 20:4-NAPE (20 μM) also exhibited a significant inhibitory effect (74.5 ± 8.9%) on the mEPSCs frequency that was prevented by the TRPV1 receptor antagonist SB 366791 but not by PF 514273 application. Our results show that 20:4-NAPE application has a significant modulatory effect on spinal cord nociceptive signaling that is mediated by both TRPV1 and CB1 presynaptic receptors, whereas peripheral inflammation changes the underlying mechanism. The switch between TRPV1 and CB1 receptor activation by the AEA precursor 20:4-NAPE during inflammation may play an important role in nociceptive processing, hence the development of pathological pain.
first_indexed 2024-03-13T03:53:09Z
format Article
id doaj.art-b73cfc7f318741579b788d9e0298b8c7
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-03-13T03:53:09Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-b73cfc7f318741579b788d9e0298b8c72023-06-22T09:31:04ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992023-06-011610.3389/fnmol.2023.11885031188503Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditionsDiana Spicarova0Vladimir Nerandzic1David Muzik2Monica Pontearso3Anirban Bhattacharyya4Istvan Nagy5Istvan Nagy6Jiri Palecek7Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, CzechiaLaboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, CzechiaLaboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, CzechiaLaboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, CzechiaLaboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, CzechiaSection of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Chelsea and Westminster Hospital, London, United KingdomDepartment of Physiology, University of Debrecen, Debrecen, HungaryLaboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, CzechiaTransient receptor potential ion channel, vanilloid subfamily, type 1 (TRPV1) cation channel, and cannabinoid receptor 1 (CB1) are essential in the modulation of nociceptive signaling in the spinal cord dorsal horn that underlies different pathological pain states. TRPV1 and CB1 receptors share the endogenous agonist anandamide (AEA), produced from N-arachidonoylphosphatidylethanolamine (20:4-NAPE). We investigated the effect of the anandamide precursor 20:4-NAPE on synaptic activity in naive and inflammatory conditions. Patch-clamp recordings of miniature excitatory postsynaptic currents (mEPSCs) from superficial dorsal horn neurons in rat acute spinal cord slices were used. Peripheral inflammation was induced by subcutaneous injection of carrageenan. Under naive conditions, mEPSCs frequency (0.96 ± 0.11 Hz) was significantly decreased after 20 μM 20:4-NAPE application (55.3 ± 7.4%). This 20:4-NAPE-induced inhibition was blocked by anandamide-synthesizing enzyme N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor LEI-401. In addition, the inhibition was prevented by the CB1 receptor antagonist PF 514273 (0.2 μM) but not by the TRPV1 receptor antagonist SB 366791 (10 μM). Under inflammatory conditions, 20:4-NAPE (20 μM) also exhibited a significant inhibitory effect (74.5 ± 8.9%) on the mEPSCs frequency that was prevented by the TRPV1 receptor antagonist SB 366791 but not by PF 514273 application. Our results show that 20:4-NAPE application has a significant modulatory effect on spinal cord nociceptive signaling that is mediated by both TRPV1 and CB1 presynaptic receptors, whereas peripheral inflammation changes the underlying mechanism. The switch between TRPV1 and CB1 receptor activation by the AEA precursor 20:4-NAPE during inflammation may play an important role in nociceptive processing, hence the development of pathological pain.https://www.frontiersin.org/articles/10.3389/fnmol.2023.1188503/full20:4-NAPETRPV1CB1anandamideNAPE-PLDspinal cord
spellingShingle Diana Spicarova
Vladimir Nerandzic
David Muzik
Monica Pontearso
Anirban Bhattacharyya
Istvan Nagy
Istvan Nagy
Jiri Palecek
Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
Frontiers in Molecular Neuroscience
20:4-NAPE
TRPV1
CB1
anandamide
NAPE-PLD
spinal cord
title Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
title_full Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
title_fullStr Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
title_full_unstemmed Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
title_short Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
title_sort inhibition of synaptic transmission by anandamide precursor 20 4 nape is mediated by trpv1 receptors under inflammatory conditions
topic 20:4-NAPE
TRPV1
CB1
anandamide
NAPE-PLD
spinal cord
url https://www.frontiersin.org/articles/10.3389/fnmol.2023.1188503/full
work_keys_str_mv AT dianaspicarova inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT vladimirnerandzic inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT davidmuzik inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT monicapontearso inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT anirbanbhattacharyya inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT istvannagy inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT istvannagy inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions
AT jiripalecek inhibitionofsynaptictransmissionbyanandamideprecursor204napeismediatedbytrpv1receptorsunderinflammatoryconditions